• Explore /
  • Poster
  • / A study into the pharmacodynamic biomarker effects of olaparib (PARP Inhibitor) ± degarelix (GnRH antagonist) given prior to radical prostatectomy (RP) CANCAP03.

A study into the pharmacodynamic biomarker effects of olaparib (PARP Inhibitor) ± degarelix (GnRH antagonist) given prior to radical prostatectomy (RP) CANCAP03.

Abstract Poster

Authors

null

Simon Pacey

University of Cambridge, Cambridge, United Kingdom

Simon Pacey , Mark David Linch , Howard Kynaston , Anne Warren , Alex Freeman , Ruth Tysoe , Greg Shaw , Krishna Narahari , Satish Kumar , Henno Martin , Bihani Kularatne , Vincent Gnanapragasam , Barry Davies , Josephine Khan , Ola Bratt , Harveer Dev , Charles Massie , Nimish Shah

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Clinical Trial Registration Number

NCT02324998

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 35)

DOI

10.1200/JCO.2019.37.7_suppl.35

Abstract #

35

Poster Bd #

C3

Abstract Disclosures

Similar Posters

First Author: Yao Zhu

First Author: Emmanuel S. Antonarakis

First Author: Laura Graham

First Author: Simon Pacey